AI-Guided TURBT for Bladder Cancer

This prospective, randomized, controlled, single‐center study evaluates whether an AInavigation planning system used during Transurethral Resection of Bladder Tumor (TURBT)can improve recurrence‐free survival in patients with non‐muscle invasive bladder cancer.Participants are randomized to receive either standard TURBT surgery or standard TURBTwith AI‐assisted real‐time tumor identification and resection margin guidance. Theprimary outcome is recurrence‐free survival, with secondary outcomes including surgicalduration, intraoperative blood loss, perioperative bleeding, and complication rates. Thestudy aims to provide high‐level evidence on the clinical utility of AI‐assisted surgicalnavigation in bladder cancer treatment.